Literature DB >> 9819124

Use of an albumin-binding domain for the selective immobilisation of recombinant capture antibody fragments on ELISA plates.

T König1, A Skerra.   

Abstract

A small albumin-binding domain (ABD) of 46 amino acids derived from streptococcal protein G was employed for the directed attachment of recombinant immunoglobulin (Ig) fragments to microtitre plates that had been coated with human serum albumin (HSA). Generic vectors were constructed in order to produce the Fv or Fab fragments fused with the ABD in Escherichia coli. Using the anti-lysozyme antibody D1.3 as the capture antibody fragment it was possible to quantify the non-radioactively labelled antigen with high sensitivity in a sandwich ELISA. The new strategy avoids denaturation or an unfavourable orientation of the Ig fragment, which can occur during direct adsorption to the microtitre plate. The HSA that serves to complex the ABD ensures efficient saturation of reactive binding sites on the plastic surface as well so that no additional blocking steps are necessary and the assay can be quickly performed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819124     DOI: 10.1016/s0022-1759(98)00112-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain.

Authors:  Jan Terje Andersen; Rikard Pehrson; Vladimir Tolmachev; Muluneh Bekele Daba; Lars Abrahmsén; Caroline Ekblad
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

2.  Design of DNA-conjugated polypeptide-based capture probes for the anchoring of proteins to DNA matrices.

Authors:  Ryan M Schweller; Pamela E Constantinou; Nicholas W Frankel; Priyanka Narayan; Michael R Diehl
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

3.  High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.

Authors:  Claudia T Mendler; Lars Friedrich; Iina Laitinen; Martin Schlapschy; Markus Schwaiger; Hans-Jürgen Wester; Arne Skerra
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 4.  The albumin-binding domain as a scaffold for protein engineering.

Authors:  Johan Nilvebrant; Sophia Hober
Journal:  Comput Struct Biotechnol J       Date:  2013-09-01       Impact factor: 7.271

5.  Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo.

Authors:  Simone Mester; Mitchell Evers; Saskia Meyer; Jeannette Nilsen; Victor Greiff; Inger Sandlie; Jeanette Leusen; Jan Terje Andersen
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.